Maternal health startup Pregistry announced recently the start of the COVID-19 Vaccines International Pregnancy Exposure Registry (C-VIPER), designed to identify the risk of common obstetric, neonatal, and infant outcomes among pregnant women around the world who received the COVID-19 vaccine. Pregistry is an emerging leader in developing and executing post-approval studies to assess the safety of medications and vaccines used … Continue reading "Maternal Health Startup Pregistry Launches COVID-19 Vaccine Study Focused on Furthering the Health of Women and Children"
